86 related articles for article (PubMed ID: 22211757)
1. Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing mice.
Ren X; Zheng N; Gao Y; Chen T; Lu W
Drug Deliv; 2012 Jan; 19(1):36-44. PubMed ID: 22211757
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil delivery from a novel three-dimensional micro-device: in vitro and in vivo evaluation.
Zheng N; Zhou M; Du C; Wang S; Lu W
Arch Pharm Res; 2013 Dec; 36(12):1487-93. PubMed ID: 23775471
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
4. In vivo distribution of 5-Fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice.
Zheng N; Zhou M; Lu W
Eur J Drug Metab Pharmacokinet; 2013 Sep; 38(3):183-90. PubMed ID: 23179563
[TBL] [Abstract][Full Text] [Related]
5. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic study and effectiveness evaluation of slow-release PLGA-5-fluorouracil microsphere.
Li J; Pu Y; Wang S; Ding M; Chen D; Zhu M
Cancer Chemother Pharmacol; 2013 Feb; 71(2):351-9. PubMed ID: 23135527
[TBL] [Abstract][Full Text] [Related]
7. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors.
Sun W; Chen Y; Yuan W
Int J Nanomedicine; 2013; 8():1499-506. PubMed ID: 23626465
[TBL] [Abstract][Full Text] [Related]
9. A novel antiproliferative drug coating for glaucoma drainage devices.
Ponnusamy T; Yu H; John VT; Ayyala RS; Blake DA
J Glaucoma; 2014; 23(8):526-34. PubMed ID: 23632409
[TBL] [Abstract][Full Text] [Related]
10. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
[TBL] [Abstract][Full Text] [Related]
11. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
12. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M
Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
14. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.
Fournier C; Hecquet B; Bouffard P; Vert M; Caty A; Vilain MO; Vanseymortier L; Merle S; Krikorian A; Lefebvre JL
Cancer Res; 1991 Oct; 51(19):5384-91. PubMed ID: 1913658
[TBL] [Abstract][Full Text] [Related]
15. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of injectable implants for intratumoral delivery of 5-fluorouracil.
Chen W; Wu Z; Yang H; Guo S; Li D; Cheng L
Pharm Dev Technol; 2014 Mar; 19(2):223-31. PubMed ID: 23432601
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the new anticancer preparation, 5-fluorouracil-polyglycolic acid-composite and its therapeutic evaluation].
Hirano M
Nihon Geka Gakkai Zasshi; 1984 Dec; 85(12):1508-17. PubMed ID: 6098806
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
